https://www.selleckchem.com/pr....oducts/calcipotriene
Conclusion - TCR-β demonstrated a higher sensitivity rate compared with TCR-γ in early-stage MF. The combined use of the TCR-β and TCR-γ clonality tests can significantly improve the diagnosis rate of early-stage MF.Purpose To demonstrate the feasibility of predicting the patient-specific treatment planning Pareto front (PF) for prostate cancer patients based only on delineations of PTV, rectum and body. Material/methods Our methodology consists of four steps. First, using Erasmus-iCycle, the Pareto fronts of 112 prostate cancer p
Like
Comment
Share
